The activation of cortical type 2 cannabinoid (CB2) receptors with cannabinoid trans-caryophyllene (TC) is effectively able to facilitate recovery among ischemic brain injury patients, according to a recent study published in The American Journal of Pathology. TC is derived from the essential oils of the Cannabis sativa plant, but its structure is very different to other classical cannabinoids - it is not associated with any psychoactive side effects...
via Health News from Medical News Today Read More Here..
No comments:
Post a Comment